|
Market Closed -
Nasdaq
16:00:00 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 2.880 USD | -1.71% |
|
-12.73% | -15.54% |
| 08-06 | B. Riley Adjusts Price Target on LifeMD to $8 From $10, Maintains Buy Rating | MT |
| 08-05 | LifeMD, Inc., Q2 2026 Earnings Call, Aug 05, 2026 |
Company Valuation: LifeMD, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 118.4 | 61.01 | 325 | 214.4 | 164.1 | 138.8 | - | - |
| Change | - | -48.47% | 432.67% | -34.03% | -23.44% | -15.43% | - | - |
| Enterprise Value (EV) | 77.74 | 61.01 | 325 | 214.4 | 164.1 | 138.8 | 138.8 | 138.8 |
| Change | - | -21.52% | 432.67% | -34.03% | -23.44% | -15.43% | 0% | 0% |
| P/E | -1.69x | -1.24x | -11.8x | -9.34x | -19.5x | -5.55x | -31.5x | 18.9x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0x | 0.2x | 0.4x | 0.3x | -0x | 0.4x | -0x |
| Capitalization / Revenue | 1.27x | 0.51x | 2.13x | 1.01x | 0.85x | 0.67x | 0.57x | 0.5x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.67x | 0.57x | 0.5x |
| EV / EBITDA | -0x | -0x | 0x | 0x | 0x | -39x | 6.95x | 4.19x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -6.38x | -182x | 10.9x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.29 | -1.57 | -0.7 | -0.53 | -0.1753 | -0.5186 | -0.0914 | 0.152 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 92.88 | 119 | 152.5 | 212.5 | 194.1 | 207.6 | 245.2 | 280.3 |
| EBITDA 1 | -38.28 | -14.66 | 11.98 | 14.38 | 15.25 | -3.564 | 19.97 | 33.1 |
| EBIT 1 | -54.3 | -43.45 | -14.49 | -16.14 | -7.67 | -21.74 | -0.761 | 12.79 |
| Net income 1 | -61.77 | -48.64 | -23.7 | -21.99 | -7.913 | -24.81 | -4.545 | 7.722 |
| Net Debt | -40.66 | - | - | - | - | - | - | - |
| Reference price 2 | 3.870 | 1.940 | 8.290 | 4.950 | 3.410 | 2.880 | 2.880 | 2.880 |
| Nbr of stocks (in thousands) | 30,593 | 31,450 | 39,203 | 43,312 | 48,136 | 48,201 | - | - |
| Announcement Date | 3/7/22 | 3/22/23 | 3/11/24 | 3/10/25 | 3/9/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.65x | - | - | - | 139M | |
| 42.86x | 10.37x | 22.86x | -.--% | 45.1B | |
| 90.45x | 49.15x | 62.41x | 0.58% | 11.93B | |
| 74.27x | 12.91x | 50.77x | 0.69% | 5.59B | |
| -66.13x | 16.81x | -110.03x | - | 4.33B | |
| -6.39x | 56.48x | -6.4x | - | 1.98B | |
| 34.44x | - | - | -.--% | 1.57B | |
| -115.27x | - | - | - | 1B | |
| 6.7x | - | - | - | 928M | |
| -15.78x | 0.17x | 1.23x | -.--% | 851M | |
| Average | 3.95x | 24.32x | 3.47x | 0.25% | 7.34B | |
| Weighted average by Cap. | 41.66x | 18.79x | 22.51x | 0.17% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- LFMD Stock
- Valuation LifeMD, Inc.
Select your edition
All financial news and data tailored to specific country editions
